Cell Line Development Market | Latest Innovations, Future Plans and Regional Forecast to 2027

The report highlights trends prevailing in the global cell line development market, and the drivers and restraints pertaining to the market growth. 

The global cell line development market, based on type, is segmented into primary cell line, hybridomas, continuous cell lines, and recombinant cell lines. The recombinant cell lines segment held the largest share of the market in 2019. This growth is ascribed to the increasing demand for recombinant cell lines in the production of therapeutic recombinant proteins. However, the hybridomas segment is estimated to register the highest CAGR during the forecast period. This growth is attributed to rising research and development activities for novel biologics. 

To request a sample copy or view summary of this report, click the link below:  https://www.theinsightpartners.com/sample/TIPHE100001196/

Stable cell lines are widely used in a wide range application, including biologics production, drug screening, and gene functional studies. The COVID-19 pandemic led to disruptions in all phases of drug development, and it has compelled many pharmaceutical companies and clinical research organizations (CROs) to put their clinical studies on hold. The new government policies, stay-at-home orders, social distancing norms, and widespread anxiety are among the prime challenges faced by researchers conducting the ongoing studies. 

The growth of the cell line development market is attributed to factors such as increasing adoption of regenerative medicines, rising prevalence of cancer in the world, and mounting investments in R&D by pharmaceutical and biotechnology companies. However, the risks associated with cell line contamination hinder the growth of this market. Merck KGaA, Thermo Fisher Scientific Inc., Selexis SA (JSR Corporation), BioFactura, Inc., Corning Incorporated, Sartorius AG, Lonza, GENERAL ELECTRIC, LakePharma, Inc., and WuXiAppTec Group are among the leading companies operating in the global cell line development market.
 

Cell Line Development Market, by Region, 2019 (%) 

The Report Segments Global Cell Line Development Market as Follows: 

By Type

• Primary Cell Line
• Hybridomas
• Continuous Cell Lines
• Recombinant Cell Line

By Product

• Equipment
• Media & Reagent

By Application

• Drug Discovery
• Bioproduction
• Tissue Engineering

Global Cell Line Development Market – By Geography

North America

U.S.

Canada

Mexico

Europe

UK

Germany

France

Asia Pacific (APAC)

Japan

China

India

Middle East & Africa (MEA)

U.A.E

Saudi Arabia

South Africa

South and Central America (SCAM)

Brazil

Buy Now This Report @ https://www.theinsightpartners.com/buy/TIPHE100001196/

Table of Contents:

Introduction

Key Takeaways

Research Methodology

Cell Line Development Market Landscape

Cell Line Development Market – Key Market Dynamics

Cell Line Development Market – Global Market Analysis

Cell Line Development Market – Revenue and Forecasts to 2027 – Product Type

Cell Line Development Market – Revenue and Forecasts to 2027 – Application

Cell Line Development Market – Revenue and Forecasts to 2027 – Compound

Cell Line Development Market Revenue and Forecasts to 2027 – Geographical Analysis

Industry Landscape

Cell Line Development Market, Key Company Profiles

Appendix

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Contact Us:

Call: +1-646-491-9876

Email: sales@theinsightpartners.com